Inventor · disambiguated record
Duncan Walker
Also filed as: WALKER DUNCAN · WALKER DUNCAN H · WALKER DUNCAN HL
5 granted patents·10 pending applications·46 citations·filing 2005–2023
80Inventor score
Files withSUNESIS PHARMACEUTICALS INC7ARRAY BIOPHARMA INC3KYMERA THERAPEUTICS INC3ARKIN MICHELLE1TUNQUIST BRIAN J1
Top patents by PatentIndex Score
15 records- 0195US11857535B2Methods of treating mutant lymphomasKYMERA THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·6 cites·30 claims
- 0292US7968565B2Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acidSUNESIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 28, 2011·33 cites·1 claims
- 0384US8822493B2SNS-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2013·Granted Sep 2, 2014·5 cites·11 claims
- 0474US9980949B2SNS-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2014·Granted May 29, 2018·1 cites·7 claims
- 0569US2024316004A1Methods of treating mutant lymphomasKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0668US9561214B2Method of treatment using inhibitors of mitosisTUNQUIST BRIAN J·Filed 2009·Granted Feb 7, 2017·1 cites·3 claims
- 0766US2018316309A1Sns-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0857US2011263524A1Sns-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 0956US2018338958A1Method of treatment using inhibitors of mitosisARRAY BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 1056US2006063795A1SNS-595 and methods of using the sameARKIN MICHELLE·Filed 2005·Application pending·0 cites
- 1153US2014205680A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1253US2023277519A1Irak4 degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1352US2017172988A1Method of treatment using inhibitors of mitosisARRAY BIOPHARMA INC·Filed 2016·Application pending·0 cites
- 1451US2018098975A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1533US2015231117A1Arry-520 for use in treating cancer in a patient with low aagARRAY BIOPHARMA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Duncan Walker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →